ResearcherUniversity of CalgaryNo recent work listed

Elijah Dixon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8680-9817, 0009-0002-5710-1358; OpenAlex author ID A5019051697. Sources: ClinicalTrials.gov.

Their work

Papers: 2
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Trials 1

Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy Principal investigator NCT00841607 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Freddie Bray · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Neil Donald Merrett · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Citadel Jungco Cabasag · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Sue Evans · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Jacques Ferlay · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Isabelle Soerjomataram · 1 shared paper, 2022 · strength 0.12
- Paper Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. DOI 10.1038/s41416-022-01752-3 ↗
Andrew M. McKay · 1 shared paper, 2011 · strength 0.03
- Paper Feasibility of identifying pancreatic cancer based on serum metabolomics. DOI 10.1158/1055-9965.epi-10-0712 ↗
Oliver F. Bathe · 1 shared paper, 2011 · strength 0.03
- Paper Feasibility of identifying pancreatic cancer based on serum metabolomics. DOI 10.1158/1055-9965.epi-10-0712 ↗
Hans J. Vogel · 1 shared paper, 2011 · strength 0.03
- Paper Feasibility of identifying pancreatic cancer based on serum metabolomics. DOI 10.1158/1055-9965.epi-10-0712 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.